Deciphera Pharmaceuticals (DCPH) Misses Q1 EPS by 1c

Deciphera Pharmaceuticals (NASDAQ: DCPH) reported Q1 EPS of ($0.60), $0.01 worse than the analyst estimate of ($0.59). Revenue for the quarter came in at $33.4 million versus the consensus estimate of $35.69 million.

For earnings history and earnings-related data on Deciphera Pharmaceuticals (DCPH) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Terra Innovatum Global N.V. (NKLR) Misses Q2 EPS by 12c
• The free USDA tool that tracks egg prices at $0.62/dozen before your data vendor does